Week 3 Flashcards
Components of a nucleotide (3) and bond involved
- nitrogenous base
- sugar
- phosphate
- linked by phosphodiester bonds
Difference between nucleotides and nucleosides
Nucleotides include phosphates attached on nucleoside
Clinical significance of using RNA as template
- Cell will first makes everything for RNA and then convert it to DNA structure
- dUMP to dTMP through RR (ribonucleotide reductase)
- used as treatment for cancer by inhibiting process of methylenation of uracil to thymine to stop proliferation of cell
Clinical significance of different classes of amino acids/ how is central dogma affected by mutations?
if mutation is made to DNA (translation/transcription) can change which AA is added to protein, if the AA added is not from similar family of original AA then will change structure of that specific protein and protein will not be able to carry out its function correctly
Forms of Lipid
- Triglyceride: storage form of lipid
- Cholesterol: provides fluidity to inside of cell membrane
- Phospholipids: main component of cell membrane, ampiphilic
- Glycolipids: lipid attached to sugar molecule, allow for cell to cell interactions
Monosaccharides
glucose, fructose, galactose, ribose, deoxyribose; can be classified in aldose or ketose
Diasccharide
has 2 mono joined by O bonds
Lactose- glucose and galactose
Fructose- glucose and fructose
Maltose- 2 glucose
Oligosaccharide
has 3-12 mono joined by O or N bonds
Glycosidic bond
O bonds: bind sugars together
N bonds: bind sugar to amine
Epimers
- Same chemical formula,
- Differ in where OH’s are around asymmetric carbon (glucose and galactose)
Enantiomers
- two compounds that are mirror images but are not superimposable
- where last OH group is at on sugar (D-right, L-left)
Polysaccharides
- homo: made of same kind of sugar; glycogen
- hetero: made of mult. kinds of sugar
List the organelles found in a typical eukaryotic cell and describe their functions (7)
- Nucleus: Contains genetic information
- Smooth ER: Synthesis of lipids, Ca storage
- Rough ER: Where mRNA is translated and proteins are made
- Mitochondria: Produces energy for the cell to use in day to day activities
- Lysosome: Degrades various biochemical substances that are seen as waste and distributes them in vesicles to be released into extracellular space.
- Cytoplasm: Holds cell shape and allows for movement of various components in cell.
- Golgi apparatus: Where proteins are adjusted and then packaged for transport
plasma membrane: -made of? -function?
- made of lipid bi-layer, with hydrophilic heads and hydrophobic tails.Contain different types of proteins and cholesterol which add to their fluidity and function
- barrier of the cell and controls what goes in and out
Driving force for movement of water and how it functions
Osmosis-passive transport that flows from areas of high concentration to low concentration to achieve equilibrium.
Types of receptors and how they work (4)
- Ligand: when activated will open/close ion channels, will make chemical into electrical signal
- GPCR: when activated will stimulate G protein and activate signaling cascade
- Enzyme linked: when activated will act as an enzyme or regulate an enzyme; protein kinase-phosphorylates proteins to activate/inhibit
- Nuclear: when activated will bind with hormones to regulate specific genes
Effects of cholera toxin and pertussis on body
- Cholera: keeps As in active form so GTP is to remain bound and which increases adenylyl cyclase – increase cAMP – increases PKA– increases pumping of electrolytes to lumen–water follows–causes diarrhea
- Pertusis: Ai is inhibited–reduces inhibition of adenylyl cyclase–increased cAMP and PKA–increases pumping of electrolytes to lumen–water follows–causes diarrhea
Pharmacodynamics
actions of the drug on the body
Compare: competitive inhibitor, allosteric inhibitor, and allosteric activator
- Competitive inhibitor: Competes with agonist to bind receptor; can be overcome with increase in agonist
- Allosteric inhibitor: Binds to allosteric receptor on enzyme, changing confirmation of enzyme and preventing agonist from binding
- Allosteric activator: Binds to allosteric receptor on enzyme, changing confirmation of enzyme and allowing agonist to bind
trastuzumab (Herceptin), cetuximab (Erbitux), and bevacizumab (Avastin)
monoclonal antibodies
- Trastuzumab (Herceptin): breast cancer- Inhibits protooncogene Her2 to stop proliferation in cells that over express Her2
- Cetuximab (Erbitux): metastatic colorectal cancer and cancers of the head and neck; allosteric inhibitor on EGFR which prevents EGF from binding
- Bevacizumab (Avastin): metastatic colorectal cancer and cancers of the head and neck; binds to VEGF (ligand) preventing from binding to VEGF receptor